Structural mimicry in G protein-coupled receptors: Implications of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like receptors

Molecular Pharmacology

Volumn 60, Issue 1, 2001, Pages 1-19

  Ballesteros, Juan A ^a   Shi, Lei ^b   Javitch, Jonathan A ^b,c  

^a Novasite Pharmaceuticals Inc   (United States)

^b College of Physicians and Surgeons ^*  (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; RECEPTOR PROTEIN; RHODOPSIN;

ALPHA HELIX; BINDING SITE; CONFORMATIONAL TRANSITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN STRUCTURE; RECEPTOR BINDING; SHORT SURVEY; STRUCTURE ANALYSIS;

EID: 0034948696     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.60.1.1     Document Type: Short Survey

References (128)

1. Acetylcholine receptor channel structure probed in cysteine-substitution mutants
2. Domain approach to three-dimensional structure of rhodopsin using high-resolution nuclear magnetic resonance
3. Mapping the binding site pocket of the serotonin 5-Hydroxytryptamine2A receptor. Ser3.36(159) provides a second interaction site for the protonated amine of serotonin but not of lysergic acid diethylamide or bufotenin
4. Structural features and light-dependent changes in the sequence 306-322 extending from helix VII to the palmitoylation sites in rhodopsin: A site-directed spin-labeling study
5. Structural features and light-dependent changes in the sequence 59-75 connecting helices I and II in rhodopsin: A site-directed spin-labeling study
6. Structural features and light-dependent changes in the cytoplasmic interhelical E-F loop region of rhodopsin: A site-directed spin-labeling study
7. An α-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors
8. Integrated methods for the construction of three-dimensional models of structure-function relations in G protein-coupled receptors
9. Serine and threonine residues bend α-helices in the chi(1) = g(-) conformation
10. 2 adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6
11. Analysis and refinement of criteria for predicting the structure and relative orientations of transmembranal helical domains
12. Helix geometry in proteins
13. Spectroscopic evidence for interaction between transmembrane helices 3 and 5 in rhodopsin
14. The ligand binding site of the neurokinin 2 receptor. Site-directed mutagenesis and identification of neurokinin A binding residues in the human neurokinin 2 receptor
15. Separable binding sites for the natural agonist endothelin-1 and the non-peptide antagonist bosentan on human endothelin-A receptors
16. CHARMM: A program for macromolecular energy, minimization, and dynamics calculations
17. 1B-adrenergic receptor is a key switch residue involved in activation and catecholamine ring aromatic bonding
18. 2 dopamine receptor are important for binding and signal transduction
19. 3H]mesulergine but not [3H]ketanserin binding to 5-hydroxytryptamine2 receptors
20. Differential ergoline and ergopeptine binding to 5-hydroxytryptamine2A receptors: Ergolines require an aromatic residue at position 340 for high affinity binding
21. Static and dynamic roles of extracellular loops in G-protein-coupled receptors: A mechanism for sequential binding of thyrotropin-releasing hormone to its receptor
22. The amino terminus of the human C5a receptor is required for high affinity C5a binding and for receptor activation by C5a but not C5a analogs
23. Structure-function analysis of the β-adrenergic receptor
24. 2-adrenergic receptor
25. Conversion of antagonist-binding site to metal-ion site in the tachykinin NK-1 receptor
26. Connectivity and orientation of the seven helical bundle in the tachykinin NK-1 receptor probed by zinc site engineering
27. 2-adrenergic receptor
28. Metal-ion sites as structural and functional probes of helix-helix interactions in 7TM receptors
29. Site-directed mutagenesis of P2U purinoceptors. Positively charged amino acids in transmembrane helices 6 and 7 affect agonist potency and specificity
30. Mapping light-dependent structural changes in the cytoplasmic loop connecting helices C and D in rhodopsin: A site-directed spin labeling study
31. Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin
32. The structure of mammalian rod opsins
33. Site-directed mutagenesis of m1 muscarinic acetylcholine receptors: Conserved aspartic acids play important roles in receptor function
34. 2 receptor accessible in the binding-site crevice
35. Molecular basis for the interaction of histamine with the histamine H2 receptor
36. An activation switch in the ligand binding pocket of the C5a receptor
37. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors
38. Lipid headgroup and acyl chain composition modulate the MI-MII equilibrium of rhodopsin in recombinant membranes
39. 2-adrenergic receptor that exploits the domain structure of G-protein-coupled receptors
40. The TxP motif in the second transmembrane helix of CCR5: A structural determinant of chemokine-induced activation
41. Identification of an amino acid residue important for binding of methiothepin and sumatriptan to the human 5-HT(1B) receptor
42. Mutagenesis of the human 5-HT1B receptor: Differences from the closely related 5-HT1A receptor and the role of residue F331 in signal transduction
43. Intrahelical hydrogen bonding of serine, threonine and cysteine residues within α-helices and its relevance to membrane-bound proteins
44. Identification of a single amino acid residue responsible for the binding of a class of β-adrenergic receptor antagonists to 5-hydroxytryptamine1A receptors
45. Functional interaction of transmembrane helices 3 and 6 in rhodopsin. Replacement of phenylalanine 261 by alanine causes reversion of phenotype of a glycine 121 replacement mutant
46. Role of an α-helical bulge in the yeast heat shock transcription factor
47. Conformation of a peptide ligand bound to its G-protein coupled receptor
48. Alanine exchanges of polar amino acids in the transmembrane domains of a platelet-activating factor receptor generate both constitutively active and inactive mutants
49. 2 receptor: Contributions of the second membrane-spanning segment
50. 2 receptor is accessible in the binding-site crevice
51. 2 receptor exposed in the binding-site crevice
52. 2 receptor by the substituted-cysteine accessibility method
53. 2 dopamine receptor is exposed in the binding-site crevice
54. Use of the substituted-cysteine accessibility method (SCAM) to study the structure and function of G-protein-coupled receptors
55. 2 receptor: Accessibility in the binding-site crevice and position in the transmembrane bundle
56. 2 adrenergic receptor mapped by site-selective fluorescent labeling
57. A mutational analysis of residues essential for ligand recognition at the human P2Y1 receptor
58. Hydrophilic side chains in the third and seventh transmembrane helical domains of human A2A adenosine receptors are required for ligand recognition
59. Short-chain dehydrogenases/reductases (SDR)
60. Substituted-cysteine accessibility method
61. Site-directed mutagenesis identifies residues involved in ligand recognition in the human A2a adenosine receptor
62. The role of the cholecystokinin-B/gastrin receptor transmembrane domains in determining affinity for subtype-selective ligands
63. Geometrical and sequence characteristics of α-helices in globular proteins
64. Mutagenesis and modeling of the neurotensin receptor NTR1. Identification of residues that are critical for binding SR 4 8692, a nonpeptide neurotensin antagonist
65. The interpretation of protein structures: Estimation of static accessibility
66. 2-adrenergic receptor
67. Analysis of functional microdomains of rhodopsin
68. Mutational analysis of the relative orientation of transmembrane helices I and VII in G protein-coupled receptors
69. A network of conserved intramolecular contacts defines the off-state of the transmembrane switch mechanism in a seven-transmembrane receptor
70. Molecular characterization of the melanin-concentrating hormone/receptor complex: Identification of critical residues involved in binding and activation
71. 2 receptor
72. Probing of the location of the allosteric site on m1 muscarinic receptors by site-directed mutagenesis
73. 2-adrenergic receptor
74. Rhodopsin: The structural basis of molecular physiology
75. Universally conserved positions in protein folds: Reading evolutionary signals about stability, folding kinetics and function
76. Arrangement of transmembrane domains in adrenergic receptors. Similarity to bacteriorhodopsin
77. Human P2Y1 receptor: Molecular modeling and site-directed mutagenesis as tools to identify agonist and antagonist recognition sites
78. Demonstration by transfection studies that mutations in the adrenocorticotropin receptor gene are one cause of the hereditary syndrome of glucocorticoid deficiency
79. A single amino-acid difference confers major pharmacological variation between human and rodent 5-HT1B receptors
80. Cloning, expression, and characterization of the unique bovine A1 adenosine receptor. Studies on the ligand binding site by site-directed mutagenesis
81. The ligand-binding domain of rhodopsin and other G protein-linked receptors
82. Crystal structure of rhodopsin: A G protein-coupled receptor
83. Dual agonistic and antagonistic property of nonpeptide angiotensin AT1 ligands: Susceptibility to receptor mutations
84. Rhodopsin mutation G90D and a molecular mechanism for congenital night blindness
85. Identification of the adenine binding site of the human A1 adenosine receptor
86. Reactivity of small thiolate anions and cysteine-25 in papain toward methyl methanethiosulfonate
87. Identification of conserved aromatic residues essential for agonist binding and second messenger production at 5-hydroxytryptamine2A receptors
88. Structural features can be unconserved in proteins with similar folds. An analysis of side-chain to side-chain contacts secondary structure and accessibility
89. Geometry of proline-containing α-helices in proteins
90. Hinges, swivels and switches: The role of prolines in signalling via transmembrane α-helices
91. Site-directed mutagenesis of the rat m1 muscarinic acetylcholine receptor. Role of conserved cysteines in receptor function
92. Is there a 'lock' for all agonist 'keys' in 7TM receptors?
93. 100 Years lock-and-key concept: Are peptide keys shaped and guided to their receptors by the target cell membrane?
94. Related contribution of specific helix 2 and 7 residues to conformational activation of the serotonin 5-HT2A receptor
95. 2A serotonin receptors revealed by mutation and molecular modeling of conserved residues in transmembrane region 5
96. 2-adrenoceptor and the parathyroid hormone receptor. Zn(II) bridges between helices III and VI block activation
97. Rhodopsin activation blocked by metal-ion-binding sites linking transmembrane helices C and F
98. Environment and exposure to solvent of protein atoms. Lysozyme and insulin
99. Dopamine D4/D2 receptor selectivity is determined by a divergent aromatic microdomain contained within the second, third, and seventh membrane-spanning segments
100. Identification of two serine residues involved in agonist activation of the β-adrenergic receptor
101. Allele-specific activation of genetically engineered receptors
102. Conserved aspartic acid residues 79 and 113 of the β-adrenergic receptor have different roles in receptor function
103. Identification of residues required for ligand binding to the β-adrenergic receptor
104. Tertiary interactions between the fifth and sixth transmembrane segments of rhodopsin
105. G protein-coupled receptor activation: Analysis of a highly constrained, "straitjacketed" rhodopsin
106. 2 adrenergic receptor increases its affinity for a family of β receptor antagonists
107. 2-adrenergic receptor modify ligand-binding specificity
108. A1 adenosine receptors. Two amino acids are responsible for species differences in ligand recognition
109. Arrangement of rhodopsin transmembrane α-helices
110. Computational methods for the construction and analysis of three dimensional representations of GPCR structures and mechanisms
111. 2A-adrenergic receptors: Identification of amino acids involved in ligand binding and receptor activation by agonists
112. Site-directed mutagenesis of the m3 muscarinic receptor: Identification of a series of threonine and tyrosine residues involved in agonist but not antagonist binding
113. 1A-adrenoceptor: Orientation and function of transmembrane helix V sidechains
114. Membrane protein folding and stability: Physical principles
115. 2-adrenergic receptor
116. Assessing annotation transfer for genomics: Quantifying the relations between protein sequence, structure and function through traditional and probabilistic scores
117. 2 dopamine receptors: Mutation of a histidine residue specifically affects the binding of a subgroup of substituted benzamide drugs
118. An integrated approach to the analysis and modeling of protein sequences and structures. II. On the relationship between sequence and structural similarity for proteins that are not obviously related in sequence
119. An integrated approach to the analysis and modeling of protein sequences and structures. III. A comparative study of sequence conservation in protein structural families using multiple structural alignments
120. Amphipathic interactions of cannabinoids with membranes. A comparison between delta 8-THC and its O-methyl analog using differential scanning calorimetry, X-ray diffraction and solid state 2H-NMR
121. Structure and function in rhodopsin. Cysteines 65 and 316 are in proximity in a rhodopsin mutant as indicated by disulfide formation and interactions between attached spin labels
122. Molecular basis for the interaction of [Nle4,D-Phe7]melanocyte stimulating hormone with the human melanocortin-1 receptor
123. State-dependent disulfide cross-linking in rhodopsin
124. Tertiary interactions between transmembrane segments 3 and 5 near the cytoplasmic side of rhodopsin
125. Use of a disulfide cross-linking strategy to study muscarinic receptor structure and mechanisms of activation
126. 1-adrenergic receptor subtype-selective antagonist binding
127. A reciprocal mutation supports helix 2 and helix 7 proximity in the gonadotropin-releasing hormone receptor
128. Replacement of lysine-181 by aspartic acid in the third transmembrane region of endothelin type B receptor reduces its affinity to endothelin peptides and sarafotoxin 6c without affecting G protein coupling